🇺🇸 FDA
Patent

US 6653084

Anti-erbB-2 antibodies to human receptor related to but distinct from EGF receptor

expired A61KA61K38/00

Quick answer

US patent 6653084 (Anti-erbB-2 antibodies to human receptor related to but distinct from EGF receptor) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Nov 20 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Nov 25 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 20 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
87
CPC classes
A61K, A61K38/00